International Biotechnology Trust plc (IBT) — Capital Reinvestment Ratio
International Biotechnology Trust plc (IBT) has a Capital Reinvestment Ratio of 1.00x as of August 2025, meaning it reinvests 1% of its operating cash flow (GBX31.30 Million) in capital expenditures (GBX31.30 Million). See International Biotechnology Trust plc (IBT) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
International Biotechnology Trust plc Capital Reinvestment Ratio (2024–2025)
This chart tracks International Biotechnology Trust plc's Capital Reinvestment Ratio across 2 annual periods. Check International Biotechnology Trust plc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for International Biotechnology Trust plc (2024–2025)
Year-by-year Capital Reinvestment Ratio for International Biotechnology Trust plc from 2024 to 2025. For live market cap and broader valuation context, see IBT stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | GBX28.63 Million | GBX28.63 Million | ▲ +0.0% |
| 2024 | 1.00x | GBX45.35 Million | GBX45.35 Million | — |